79253499 - OSLER DEMOS

Information

  • Trademark
  • 79253499
  • Serial Number
    79253499
  • Registration Number
    6039141
  • Filing Date
    January 29, 2019
    5 years ago
  • Registration Date
    April 28, 2020
    4 years ago
  • Transaction Date
    September 08, 2023
    a year ago
  • Status Date
    April 28, 2020
    4 years ago
  • Published for Opposition Date
    February 11, 2020
    4 years ago
  • Location Date
    April 28, 2020
    4 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    LEE, DOUGLAS M
  • Attorney Name
    Eric Lamb
    Law Office Assigned Location Code
    M40
  • Owners
Mark Drawing Code
4000
Mark Identification
OSLER DEMOS
Case File Statements
  • GS0411: Research in the field of education; consultancy, advisory and/or information services relating to or connected with the aforementioned services
  • GS0091: Scientific apparatus and instruments, namely, hand-held devices for withdrawing and testing blood for clinical, research, and scientific purposes and parts and fittings therefor; material testing apparatus and instruments, namely, electronic apparatus for identifying and testing pathogens and biomarkers in blood for clinical, research, and scientific purposes; monitoring, measuring, signaling and control apparatus and instruments, namely, apparatus and instruments for testing blood against a panel of biomarkers for clinical, research, and scientific purposes; audiovisual receivers; computer apparatus and instruments, namely, computer hardware and computer peripheral apparatus; recorded computer software for analyzing data obtained from blood samples; downloadable computer software for analyzing data obtained from blood samples; recorded application software for analyzing data obtained from blood samples; computer hardware for data capture, collection, recording, processing, transmission, reproduction, storage and communications; electrical and electronic components for computers; parts and fittings for all the aforementioned goods
  • GS0051: Pharmaceuticals for treating viruses, infections, infectious diseases, and skin disorders; medical preparations for treating viruses, infections, infectious diseases, and skin disorders; chemical preparations and reagents for medical purposes for treating viruses, infections, infectious diseases, and skin disorders; diagnostic preparations, substances, agents, reagents, assays and materials for medical purposes; diagnostic testing preparations, substances, agents, reagents, assays and materials for medical purposes, namely, for testing blood and body fluids
  • GS0011: Assays and reagents for scientific or medical research purposes
  • GS0451: Intellectual property licensing services; licensing of technology; licensing of manufacturing technology and/or manufacturing processes; licensing of intellectual property and/or intellectual property rights; licensing of industrial property and/or industrial property rights; licensing of patents and intellectual property in the field of confidential information, technical information and/or know-how; consultancy, advisory and/or information services relating to or connected with the aforementioned services
  • GS0441: Medical services; medical testing for diagnostic purposes; medical testing, screening and analysis services relating to the diagnosis and/or treatment of disease; consultancy and advisory services relating to or connected with the aforementioned services
  • GS0101: Medical apparatus and instruments for use in obtaining blood samples; medical apparatus and instruments for testing blood for diagnostic use; medical apparatus and instruments for identifying pathogens and biomarkers from blood samples; diagnostic testing apparatus and instruments for the measurement of clinical biomarkers; parts and fittings for all the aforementioned goods
  • GS0421: Product research and development services; medical research and development services; scientific research and development services; pharmaceutical research and development services; new product design services; research, design and development of medical apparatus and instruments; research, design and development of medical diagnostic apparatus and instruments; research, design and development of diagnostic tests for the measurement of clinical biomarkers; software research, design and development services; consultancy, advisory and/or information services relating to or connected with the aforementioned services
Case File Event Statements
  • 9/8/2023 - a year ago
    42 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 9/8/2023 - a year ago
    41 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 9/8/2023 - a year ago
    40 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 9/2/2023 - a year ago
    39 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 2/28/2023 - a year ago
    38 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 2/28/2023 - a year ago
    37 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 2/28/2023 - a year ago
    36 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 2/28/2023 - a year ago
    35 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 2/28/2023 - a year ago
    34 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 9/26/2020 - 4 years ago
    33 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 9/7/2020 - 4 years ago
    32 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 9/3/2020 - 4 years ago
    31 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 7/28/2020 - 4 years ago
    30 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 4/28/2020 - 4 years ago
    29 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 2/11/2020 - 4 years ago
    28 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 2/11/2020 - 4 years ago
    27 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 2/7/2020 - 4 years ago
    26 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 1/22/2020 - 4 years ago
    25 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 1/22/2020 - 4 years ago
    24 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 1/22/2020 - 4 years ago
    23 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 1/3/2020 - 5 years ago
    22 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 12/26/2019 - 5 years ago
    21 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 12/26/2019 - 5 years ago
    20 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 12/26/2019 - 5 years ago
    19 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 12/26/2019 - 5 years ago
    18 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 12/17/2019 - 5 years ago
    17 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 12/17/2019 - 5 years ago
    16 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 12/17/2019 - 5 years ago
    15 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 7/26/2019 - 5 years ago
    14 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 7/12/2019 - 5 years ago
    13 - REFUSAL PROCESSED BY IB Type: RFNP
  • 7/5/2019 - 5 years ago
    12 - CHANGE OF NAME/ADDRESS REC'D FROM IB Type: ADCH
  • 6/22/2019 - 5 years ago
    11 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 6/21/2019 - 5 years ago
    10 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 5/19/2019 - 5 years ago
    9 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 5/18/2019 - 5 years ago
    8 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 5/3/2019 - 5 years ago
    7 - NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW Type: RFWR
  • 4/18/2019 - 5 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 4/17/2019 - 5 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 4/10/2019 - 5 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/15/2019 - 5 years ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 3/11/2019 - 5 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 3/7/2019 - 5 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR